<DOC>
	<DOCNO>NCT00134992</DOCNO>
	<brief_summary>The objective trial confirm tolerability prednisolone acetate 0.5 % eye drop test hypothesis ocular safety tolerability prednisolone acetate 0.5 % eye drop equivalent vehicle . Thus healthy volunteer select treat use crossover design .</brief_summary>
	<brief_title>A Study Compare Ocular Safety Tolerability Prednisolone Acetate 0.5 % Eye Drops Versus Vehicle Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Healthy subject either gender , 18 year old , able give inform consent A score ocular discomfort 020 mm visual analogue scale ( VAS ) prior treatment Known hypersensitivity constituent medication Known corticosteroid responder ( elevation intraocular pressure [ IOP ] ) Known allergic disposition ( e.g . hay fever ) Need ocular antiallergic treatment Wearing contact lenses Any kind current eye disease ( e.g . dry eye ) Any kind concomitant ocular treatment Any injury infection either eye last 3 month prior first application Any medication take within last 28 day prior first application , except hormonal contraceptive Concomitant previous treatment antihistamine within week prior enrolment Pregnant breast feed woman Participation another clinical study within 4 week prior enrolment Hematological disease aplastic anemia , panmyelopathy , hemolytic icterus ; severe dysfunction liver . Any medical laboratory condition , Investigator â€™ opinion , would preclude participant adhere protocol complete trial per protocol Subjects history malignancy organ system , treat untreated , within past five year , whether evidence local recurrence metastasis exist , exclude , exception localize basal cell carcinoma skin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>Prednisolone acetate</keyword>
	<keyword>eye drop</keyword>
	<keyword>tolerability</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>